Workflow
山东鲁抗医药股份有限公司第十一届董事会第九次(临时)会议决议公告

Core Points - The company held its 11th Board of Directors' 9th (temporary) meeting on September 19, 2025, where several resolutions were passed, including adjustments to the 2025 investment plan and a proposal to acquire shares in Shandong Rukang Hecheng Pharmaceutical Co., Ltd. [1][2][3] Investment Plan Adjustment - The company approved a mid-term adjustment to its 2025 investment plan, increasing the fixed asset investment by 0.08 billion yuan, bringing the total to 5.67 billion yuan, and adding four new long-term equity investment projects with an increase of 1.87 billion yuan [1][6]. Share Acquisition Proposal - The company plans to acquire 1.9231% of the shares in Shandong Rukang Hecheng Pharmaceutical Co., Ltd. through a bidding process managed by the Shandong Property Rights Exchange Center. The final amount will be determined by the bidding results [7][9]. - The acquisition is part of the company's strategic layout and aims to optimize resource allocation and improve operational decision-making efficiency [7][9]. Upcoming Shareholders' Meeting - The company has scheduled its 2025 second temporary shareholders' meeting for October 10, 2025, at 2:00 PM, which will combine on-site and online voting methods [3][22][23].